/Investor DB

AME Cloud Ventures — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Elegenelegenbio.comin𝕏May 2024

Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.

BiotechDeep TechSan Carlos, US

Matthew Hill(Executive Officer, Director)in

BoardPeter Zhou(Director)inCain McClary(Director)inJonathan Sheena(Director)in

Co-investorsACVC PartnersAndreessen HorowitzIn-Q-TelKdT VenturesRaptor GroupTriatomic Capital+1 more

Emaema.aiMar 2024

Ema builds "Universal AI Employees" — AI agents designed to perform business tasks and automate repetitive work across an organization.

AI & Machine LearningEnterprise SoftwareFuture of WorkSaaS

Surojit Chatterjee(Co-Founder & CEO)inSouvik Sen(Co-Founder & CTO)in

Co-investorsAccelColle Capital PartnersHitachi VenturesS32Section 32Transpose Platform Management+7 more

Overviewoverview.aiin𝕏Seed · Nov 2024

Overview AI builds AI-powered vision systems that detect manufacturing defects in real-time across production lines, learning and adapting to any product within hours.

Advanced ManufacturingAI & Machine LearningDeep TechIoTRoboticsSan Francisco, US

Austin Appel(Founder)inRussell Nibbelink(Founder)inChristopher Van Dyke(Founder)inXiaoyang Kao(Founder)inDaniel Chen(GTM)Sarah Ham(Future COO)

Co-investorsAlumni VenturesArray Ventures Management LlcBlumberg CapitalCorrelation VenturesGV (Google Ventures)Homebrew+13 more

Voicepanelvoicepanel.comin𝕏Seed · May 2024 · $2M

Voicepanel provides customer research tools to help companies understand their customers faster and more reliably than traditional research methods.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareMarketing TechSaaSSan Francisco, US

Asa Schachar(CTO)inJohn Provine(CEO)inDavidinJohn(Co-founder)Asa(Co-founder)

Co-investorsY CombinatorMaiora Rebel VenturesRebel FundLiquid VenturesRomulus CapitalSequoia Capital+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.